Physician profile
Travis D Gilbert
NPI 1700067576
$27,721.68
in general payments reported to CMS, 2019-2025
18 companies · $4,450 in 2025
The $4,450 reported for 2025 was more than what 97% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $59.42 · 2020: $128 · 2021: $393 · 2022: $1,507 · 2023: $309 · 2024: $21K · 2025: $4,450.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $24K · Food and Beverage: $1,634.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $24,000.00 |
| Food and Beverage | $1,633.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $25,409.46 | 2020-2025 | |
| Caldera Medical, INC | $672.58 | 2021-2022 | |
| Aspira Women'S Health INC | $307.72 | 2022 | |
| Boston Scientific Corporation | $248.93 | 2022-2024 | Upsylon, Advantage System, Obtryx System - Curved |
| Hologic Sales and Service, LLC | $218.69 | 2024-2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System, Aptima |
| Astellas Pharma US INC | $162.62 | 2021-2025 | Veozah, Myrbetriq |
| Abbvie INC. | $143.56 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $117.66 | 2019-2024 | |
| Ethicon US, LLC | $108.64 | 2020-2021 | |
| Pfizer INC. | $102.23 | 2019-2022 | |
| Axonics, INC. | $43.05 | 2022-2023 | Axonics |
| Sumitomo Pharma America, INC. | $39.10 | 2023 | Myfembree |
| Coloplast Corp | $29.78 | 2023-2025 | Restorelle |
| Amag Pharmaceuticals, INC. | $25.57 | 2019 | |
| Shield Therapeutics INC | $24.52 | 2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $24.17 | 2023 | |
| Exeltis, USA INC. | $23.96 | 2021 | |
| Biogen, INC. | $19.44 | 2025 | Zurzuvae |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Travis Gilbert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.